Nuclear Medicine Radioisotopes Market Set to Surge as Precision Diagnostics and Cancer Care Drive Global Demand 2026 | Top Companies - Cardinal Health, Inc, Bayer AG, GE Company (GE Healthcare).

Market Overview:

The Nuclear Medicine Radioisotopes Market is projected to reach at a CAGR 12.8% during the forecast period (2024-2031).

The Nuclear Medicine Radioisotopes Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/nuclear-medicine-radioisotopes-market?sz

The Nuclear Medicine Radioisotopes Market encompasses the production, distribution, and clinical use of radioactive isotopes for diagnostic imaging and therapeutic applications. These radioisotopes enable visualization of organ function, detection of diseases such as cancer and cardiac disorders, and targeted radiation therapy, supporting precision medicine across hospitals, diagnostic centers, and research institutions worldwide.

Recent Key Developments of United States:

✅ January 2026: NorthStar Medical Radioisotopes partnered with YAP Therapeutics to supply Ac-225 and provide CDMO services for developing radiopharmaceuticals targeting cancer and chronic diseases.

✅ December 2025: NorthStar Medical Radioisotopes advanced Ac-225 production with analytical methods for accurate quantification and radiochemical purity in drug products, supporting therapeutic applications.

✅ October 2025: The Society of Nuclear Medicine and Molecular Imaging (SNMMI) reported a renaissance in domestic radioisotope production, highlighting DOE grants like $32 million for a Mo-99 facility in Wisconsin, $75 million for Oak Ridge National Laboratory's isotope center, and a new facility in West Valley, UT.

Recent Key Developments of Europe:

✅ December 2025: The PRISMAP consortium, involving European facilities like ILL's reactor for Lutetium-177 production, concluded on December 31, having funded projects for high-purity radionuclides in medical research.

✅ October 2025: Nusano and Ariceum Therapeutics (Berlin-based) signed a multi-isotope supply agreement for Ac-225 and Lu-177 to support clinical trials like Ac-225 SSO110 for lung cancer and Merkel cell carcinoma.

✅ September 2025 (noted in Oct updates): The Euratom Supply Agency's Observatory on Medical Radioisotopes met to review 2025-2026 reactor schedules, discussed the European Radioisotope Valley under SAMIRA, and updates on Lutetium-177 production in Romania.

List of the Key Players in the Nuclear Medicine Radioisotopes Market:

Cardinal Health, Inc
NTP Radioisotopes SOC Ltd
Nordion Inc., (Sotera Health company)
Bayer AG
GE Company (GE Healthcare)
NorthStar Medical Radioisotopes, LLC

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/nuclear-medicine-radioisotopes-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Nuclear Medicine Radioisotopes Market:

By Type of Radioisotopes: Fluorine-18, Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-223) and Alpharadin, Actinium-225 (Ac-225.

By Application: Cardiology, Oncology, Thyroid, Neurology, Other.

By End-User: Hospitals, Diagnostic centers, Specialty Clinics, Education and Research institutes, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=nuclear-medicine-radioisotopes-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Nuclear Medicine Radioisotopes market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Nuclear Medicine Radioisotopes Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Nuclear Medicine Radioisotopes market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Nuclear Medicine Radioisotopes Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Nuclear Medicine Radioisotopes Market in 2025?
◆ What is the projected growth rate of the Nuclear Medicine Radioisotopes Market through 2033?
◆ Who are the key players in the Nuclear Medicine Radioisotopes Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.